合

合创汽车科技有限公司 Tech Stack

Biologics development and regulatory support for large-molecule therapeutics

广州, 广东 ~21 employees

合创汽车科技 operates a research and manufacturing unit focused on biologics development, with particular emphasis on large-molecule protein characterization and upstream process development. The tech stack—CATIA, CANoe, HPLC, LC-MS, SDS-PAGE—reflects hands-on analytical chemistry and bioprocess work rather than software engineering. The hiring mix (research-heavy with emerging QC and manufacturing functions) and active pain points around QC lab buildout and supplier evaluation suggest a scaling CRO/CDMO operation navigating the cost and compliance demands of clinical-stage biologics.

Tech Stack 10 technologies

Core StackCATIA CANoe SDS-PAGE HPLC LC-MS Word Excel PowerPoint CAD Microsoft Office

What 合创汽车科技有限公司 Is Building

◆Challenges

Budget control
Resource coordination
Complex issues in clinical trials
Upstream process development for large molecule proteins
Optimizing procurement process
Supplier evaluation
Cost control
Building qc team
Establishing qc lab platform
Supporting regulatory submissions

▲Active Projects

Ind/bla registration for large molecule drug projects
Clinical project lifecycle management
Market research and competitor analysis
Protein quality analysis method development and validation
Protein sample characterization
Upstream process development for large molecule proteins
Cell line stability research
Large procurement project negotiation
Lab reagent procurement
Design stability study plan

Hiring Activity

Minimal20 roles · 0 in 30d

Department

Research

Engineering

Healthcare

Manufacturing

Procurement

Seniority

Mid

Senior

Manager

Notable leadership hires: QC Lead, Technology Lead

Company intelligence

Find more companies like 合创汽车科技有限公司 by tech stack, pain points and active projects

Get started free

About 合创汽车科技有限公司

合创汽车科技 is a biologics development and regulatory services firm based in Guangzhou, China. The company operates across upstream process development, protein characterization, analytical method validation, and IND/BLA regulatory submissions for large-molecule drug candidates. Current focus areas include cell line stability research, clinical project lifecycle management, and establishment of an in-house QC lab platform. The organization is structured around research and engineering teams, with active recruitment in QC and manufacturing roles to support scaling.

Headquarters广州, 广东

Company Size~21 employees

Hiring MarketsChina

Frequently Asked Questions

What is 合创汽车科技's tech stack?

Primary tools: CATIA (CAD), CANoe (automotive/embedded simulation), HPLC, LC-MS, SDS-PAGE, and Microsoft Office. The stack reflects analytical chemistry and bioprocess development workflows rather than software-centric operations.

What is 合创汽车科技 working on?

Large-molecule drug development including IND/BLA regulatory submissions, upstream protein process development, protein quality analysis method validation, cell line stability research, and QC lab platform buildout. Also managing clinical project lifecycle and supplier negotiations.